FDA
-
-
-
-
-
-
-
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer
-
-
-
-
-
-
-
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List
-
-
-
-
-
-
-
AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results
-
-
-
-
-
-
-
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
-
-
-
-
-
-
-
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
-
-
-
-
-
-
-
AngioDynamics (ANGO) Receives 510(k) Clearance for AlphaVac F18 System
-
-
-
-
-
-
-
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
-
326,420 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

